Definitive Analysis
Definitive Analysis
Financial Statements
Periods / Units
Fundamentals
Valuations
Miscellaneous
Analysis Mode
Full Access
See Pricing Start Trial

biote Corp.

Intrinsic Value Analysis (Discounted Cash Flow)Industry: Medical - Care FacilitiesSector: Healthcare

Fair Value Summary

Current Price$2.63
5Y Range3.76 – 6.44
5Y Selected5.10
(-) Safety Margin81.00%
5Y Buy Price$0.97
Upside (to Buy Price)-63.09%
10Y Range3.58 – 5.85
10Y Selected4.71
(-) Safety Margin81.00%
10Y Buy Price$0.90
Upside (to Buy Price)-65.88%

Company Predictability & Safety

MetricValue
Revenue R2 (5Y)0.9849
Revenue R2 (10Y)0.9803
Net Income R2 (5Y)0.6414
Net Income R2 (10Y)0.5376
EBITDA R2 (5Y)0.1265
EBITDA R2 (10Y)0.0497
FCF R2 (5Y)0.0329
FCF R2 (10Y)0.0102
Safety Score0.1900

DA 10-Year Projection

Metric2025202620272028202920302031203220332034
% Growth-15.88%-13.68%-11.47%-9.26%-7.05%-4.84%-2.63%-0.42%1.79%4.00%
Revenue165.87143.18126.77115.03106.93101.7599.0898.66100.43104.45
EBITDA29.9725.8722.9020.7819.3218.3817.9017.8218.1418.87
D&A-2.20-1.90-1.68-1.53-1.42-1.35-1.32-1.31-1.33-1.39
EBIT27.7623.9721.2219.2517.9017.0316.5816.5116.8117.48
Pro forma Taxes-1.48-1.28-1.13-1.03-0.96-0.91-0.89-0.88-0.90-0.93
NOPAT26.2822.6920.0818.2316.9416.1215.7015.6315.9116.55
Capital Expenditures-3.24-2.80-2.48-2.25-2.09-1.99-1.94-1.93-1.96-2.04
NWC Investment-2.57-1.86-1.35-0.96-0.67-0.42-0.22-0.030.150.33
(+) D&A2.201.901.681.531.421.351.321.311.331.39
Free Cash Flow22.6719.9317.9416.5415.6115.0614.8614.9815.4316.22
Diluted Shares Outstanding36,977,731.5036,977,731.5036,977,731.5036,977,731.5036,977,731.5036,977,731.5036,977,731.5036,977,731.5036,977,731.5036,977,731.50

Discounting Periods

MetricDec-25Dec-26Dec-27Dec-28Dec-29Dec-30Dec-31Dec-32Dec-33Dec-34
Period Start9/30/251/1/261/1/271/1/281/1/291/1/301/1/311/1/321/1/331/1/34
Period End12/31/2512/31/2612/31/2712/31/2812/31/2912/31/3012/31/3112/31/3212/31/3312/31/34
Mid-Point11/15/257/2/267/2/277/1/287/2/297/2/307/2/317/1/327/2/337/2/34
Time (t)0.100.451.452.463.464.465.466.467.468.46
Valuation Date1/17/26

Base Case Projected Flows

WACC: 9.10%Terminal Growth: 2.49%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.960.880.810.740.680.620.570.520.48
PV UFCF22.4719.1615.8113.3511.5510.219.248.548.067.77
Raw: 242.05
171.46
Raw: 251.64
115.33

Base Case Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value253.81241.49
(-) Net Debt76.4676.46
Equity Value177.34165.02
(/) Shares Out36.9836.98
Fair Value$4.80$4.46
(-) Safety Margin81.00%81.00%
Buy Price$0.91$0.85
Current Price$2.63$2.63
Upside (to Buy Price)-65.29%-67.70%

Conservative Projected Flows

WACC: 10.10%Terminal Growth: 1.99%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.960.870.790.720.650.590.540.490.44
PV UFCF22.4519.0815.6113.0611.199.818.798.057.537.19
Raw: 196.31
134.12
Raw: 204.09
86.19

Conservative Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value215.51208.93
(-) Net Debt76.4676.46
Equity Value139.04132.47
(/) Shares Out36.9836.98
Fair Value$3.76$3.58
(-) Safety Margin81.00%81.00%
Buy Price$0.71$0.68
Current Price$2.63$2.63
Upside (to Buy Price)-72.78%-74.07%

Aggressive Projected Flows

WACC: 8.10%Terminal Growth: 2.99%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.970.890.830.760.710.650.600.560.52
PV UFCF22.4919.2416.0313.6611.9210.649.719.068.638.40
Raw: 314.67
231.17
Raw: 327.13
162.82

Aggressive Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value314.51292.60
(-) Net Debt76.4676.46
Equity Value238.05216.14
(/) Shares Out36.9836.98
Fair Value$6.44$5.85
(-) Safety Margin81.00%81.00%
Buy Price$1.22$1.11
Current Price$2.63$2.63
Upside (to Buy Price)-53.40%-57.69%

Reverse DCF: Market Implied Growth

Current Price$2.63
WACC Used9.1%
IMPLIED REVENUE GROWTH104.83%
Metric2027202820292030203120322033203420352036
Implied Revenue400.75820.871,681.413,444.117,054.7014,450.4329,599.4060,629.62124,190.07254,383.47
Constant Implied Growth104.83%104.83%104.83%104.83%104.83%104.83%104.83%104.83%104.83%104.83%
Implied Free Cash Flow0.040.080.170.340.711.452.966.0612.4225.44
Discount Factor0.930.810.740.680.620.570.520.480.440.40
Present Value of Implied FCF0.040.070.120.230.440.821.552.905.4510.23

Rolling Historical DCF (Backtest)

Valuation based on actual realized growth.
YearValuation DateActual PriceRealized Growth (5Y)Calculated Fair ValueValuation Delta
20192019-12-31$10.05-29.05%$6.58-34.49%

Monte Carlo Simulation (1,000 Iterations)

Mean Fair Value
$4.61
Median
$4.47
10th Percentile
$3.55
90th Percentile
$5.83

Fair Value Distribution

$2.43 - $2.78
3
$2.78 - $3.13
17
$3.13 - $3.48
64
$3.48 - $3.84
125
$3.84 - $4.19
145
$4.19 - $4.54
179
$4.54 - $4.89
133
$4.89 - $5.24
123
$5.24 - $5.60
77
$5.60 - $5.95
52
$5.95 - $6.30
25
$6.30 - $6.65
23
$6.65 - $7.01
13
$7.01 - $7.36
6
$7.36 - $7.71
7
$7.71 - $8.06
2
$8.06 - $8.41
2
$8.41 - $8.77
2
$8.77 - $9.12
0
$9.12 - $9.47
2